MSME (Udyam registered) Ministry of MSME
- Category
- Small (2023-24)
- Udyam number
- UDYAM-TS-02-0017947
Cystron Pharma Private Limited - pharma in Secunderabad, Telangana, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹4.67 Cr
▲ 137% YoY
Net profit · FY 2025
₹43.49 Lakh
Net margin 9.3%
EBITDA · FY 2025
₹1.01 Cr
EBITDA margin 21.6%
Authorised capital
₹1.5 Cr
Registered with MCA
Paid-up capital
₹1.1 Cr
Issued & subscribed
Open charges
₹3.4 Cr
Secured borrowings
Company age
15 yrs
Est. 2011
Directors on board
3
As per MCA filings
About Cystron Pharma Private Limited
Data last updated:
Cystron Pharma Private Limited is a private limited company based in Secunderabad, Telangana, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 08 July 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2011PTC075439. Its GSTIN is 36AAGCP1075P1ZY (Telangana).
The company has an authorised share capital of ₹1.5 Cr and a paid-up capital of ₹1.1 Cr. It was formerly known as Panchakalyani Food Products Private Limited. It is led by directors including Prathivenkateswararao and Venkata Subbu Sridhar Anantharaju.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Secunderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.67 Cr, a growth of 137% compared to the previous year. For the same year it recorded a net profit of ₹43.49 Lakh (net margin 9.3%) and EBITDA of ₹1.01 Cr (EBITDA margin 21.6%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 34% over five years.
As per MCA filings, the company has open charges of ₹3.4 Cr on record.
Cystron Pharma Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-TS-02-0017947). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website cystronpharma.com.
Company details
CIN U24100TG2011PTC075439
Registration Number 075439
Incorporation Date 08 July 2011
ROC Hyderabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-TS-02-0017947
CIN history
Cystron Pharma has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is U24100TG2011PTC075439, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100TG2011PTC075439 | Current |
| U15400TG2011PTC075439 | Previous |
| U15400AP2011PTC075439 | Previous |
Key People
Prathivenkateswararao Director Sailendra Kotikalapudi Additional Director Venkata Subbu Sridhar Anantharaju Director Recognitions & Rankings of Cystron Pharma
Contact details
Cystron Pharma Private Limited's registered office is in Secunderabad, Telangana. Its website is cystronpharma.com. Its e-mail address is in the company report.
- Email
- Website
- Social Media
- Registered Address207 My Home Tycoon, Landmark – Lifestyle Building Kundan Bagh, Secunderabad, Telangana, India – 500016
- IndustryPharma, API Manufacturers
To see the full contact details of Cystron Pharma Private Limited, buy the company report.
Comprehensive company report
Cystron Pharma Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Cystron Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Cystron Pharma Private Limited, buy the company report.
Financials of Cystron Pharma Private Limited
FY 2025 filings availableCystron Pharma Private Limited reported revenue of ₹4.67 Cr (up 137% YoY) for FY 2025.
Revenue · FY 2025
₹4.67 Cr ▲ 137%
Net profit · FY 2025
₹43.49 Lakh margin 9.3%
EBITDA · FY 2025
₹1.01 Cr margin 21.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 137%
3 years · compounded
▼ 2%
5 years · compounded
▲ 34%
EBITDA CAGR growth
1 year
▲ 195%
3 years · compounded
▲ 8%
5 years · compounded
▲ 34%
Revenue has grown at a compounded annual rate (CAGR) of 34% over five years, including 137% growth in the latest year. EBITDA rose 195% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.01 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹43.49 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.6% | ||||
| Net Profit Margin | 9.3% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cystron Pharma Private Limited, buy the company report.
Board of directors of Cystron Pharma Private Limited
Cystron Pharma has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prathivenkateswararao Also directs: Parameshwari Associates LLP, Akv Logistics Private Limited, Mahanya Logistics Private Limited and 2 more | Director | 09 Mar 2022 | 4 Years 8 Months | Current |
| Sailendra Kotikalapudi Also directs: K9 Nutra Private Limited | Additional Director | 25 Mar 2025 | 1 Years 7 Months | Current |
| Venkata Subbu Sridhar Anantharaju Also directs: Sravani Real Estates Private Limited | Director | 10 Mar 2016 | 10 Years 8 Months | Current |
Auditor
Cystron Pharma Private Limited is audited by MEENAVALLI & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| MEENAVALLI & ASSOCIATES | FY 2021 | 012208S |
Shareholding
The shareholding of Cystron Pharma Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Cystron Pharma Private Limited, buy the company report.
Charges & borrowings
Open charges
₹3.4 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 22 Mar 2021 | 100440177 | State Bank of India | ₹3.4 Cr | Open |
To see the full charge records of Cystron Pharma Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cystron Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cystron Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cystron Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAGCP1075P1ZY | Telangana | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Cystron Pharma Private Limited, buy the company report.
Recent activity
Cystron Pharma Private Limited has 9 board changes on record since 2016: 3 appointments and 6 cessations. The latest: Sailendra Kotikalapudi was appointed as Additional Director on 25 Mar 2025.
AGM
Cystron Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Cystron Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad.
Appointed
Sailendra Kotikalapudi was appointed as Additional Director.
Ceased
Praveen Kumar Jamjala ceased to be Director.
Charges
A charge with State Bank Of India of Rs. 3.40 Cr registered on 22 Mar 2021 with Charge ID 100440177 was modified on 28 Dec 2022.
Ceased
Prathivenkateswararao ceased to be Additional Director.
Ceased
Mouni Sai Srinath Prathi ceased to be Director.
Appointed
Prathivenkateswararao was appointed as Director.
Charges
A charge with State Bank Of India amounted to Rs. 3.40 Cr with Charge ID 100440177 was registered on 22 Mar 2021.
Ceased
Narendra Babu ceased to be Additional Director.
Ceased
Ravi Kumar Yellamelli ceased to be Director.
Ceased
Yellamelli Surekha ceased to be Director.
2 earlier events are in the company report.
Frequently asked questions
Cystron Pharma is an active private limited company based in Secunderabad, Telangana, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 08 July 2011 (15+ years old) and is registered under CIN U24100TG2011PTC075439.
Cystron Pharma has 3 current directors:
- Prathivenkateswararao - Director
- Sailendra Kotikalapudi - Additional Director
- Venkata Subbu Sridhar Anantharaju - Director
The latest financial statements of Cystron Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cystron Pharma is 36AAGCP1075P1ZY, registered in Telangana.
The CIN (Corporate Identification Number) of Cystron Pharma is U24100TG2011PTC075439. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cystron Pharma was incorporated on 08 July 2011, making it 15+ years old. It is registered with the Registrar of Companies, Hyderabad.
Sailendra Kotikalapudi was appointed as Additional Director on 25 Mar 2025. Praveen Kumar Jamjala ceased to be Director on 01 Apr 2024. Prathivenkateswararao ceased to be Additional Director on 29 Sep 2022. Cystron Pharma has 9 board changes on record in total.
Yes, Cystron Pharma is registered as a small enterprise under Udyam registration (number: UDYAM-TS-02-0017947).
Cystron Pharma can be reached through the website cystronpharma.com. Its registered office is in Secunderabad, Telangana, India.
The registered office of Cystron Pharma is at 207 My Home Tycoon, Landmark – Lifestyle Building Kundan Bagh, Secunderabad, Telangana, India – 500016.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages